The ACRF Image X Institute is a centre for innovation in radiation therapy and cancer imaging technologies.
We create, share and apply scientific knowledge to improve health by building new technology for cancer imaging and targeted radiation therapy.
We engage with industry, hospitals, international collaborators and universities to forge relationships that help take our projects from lab bench to patient bedside.
Image X Researchers Awarded by AAPM
Congratulations to two of our researchers, who have been recognized for their innovations in physics in medicine. Emily Hewson and Dr Tess Reynolds have each been given top awards by the American Association for Physics in Medicine (AAPM), and as a result their research will be under the spotlight at the world’s largest medical physics conference this winter.
ADAPT Trial – Early Results
Early results of the ADAPT clinical trial show that faster imaging with a lower dose + higher quality is possible, bringing improved care to future lung cancer patients. In this trial, Respiratory Motion Guided (RMG) 4DCBCT will be implemented for the first time on lung cancer patients. RMG-4DCBCT adapts the image acquisition as the patient’s breathing changes (i.e. if the patient breathes faster, imaging data is acquired faster). By adapting the acquisition to the dynamic patient we are able to acquire personalised images of a patients lungs for radiotherapy treatments.
Emily Hewson featured in Physics World
PhD Candidate Emily Hewson has been interviewed by new website Physics World about her recently published article assessing multileaf collimator tracking and gating of the radiation therapy beam during treatment.
“Our implementation of KIM to monitor tumour motion, combined with either gating or MLC tracking improves the availability of intrafraction motion adaption for all clinics with standard treatment machines,” says Hewson. “One of the major barriers to implementing real-time adaptive radiotherapy in many countries has been a lack of finances and resources. The adaptive methods we compared could potentially overcome these obstacles and bring intrafraction motion adaptation into standard clinical practice at any cancer treatment facility that treat patients using a modern linear accelerator.”
Read more news here.
The ACRF Image X Institute is proudly supported by the Australian Cancer Research Foundation.